Product
T2026
Aliases
Absorption enhancer excipient
1 clinical trial
2 indications
Indication
ObesityIndication
Type 2 Diabetes MellitusClinical trial
A Phase 1, Randomised, Double-blind, Placebo-controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Oral Ecnoglutide Tablet in Healthy Adult ParticipantsStatus: Recruiting, Estimated PCD: 2024-07-01